Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above-Reference-Cited by-同舟云学术

Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above

Published:2017-11-14 Issue:20 Volume:136 Page:1878-1891
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Vallejo-Vaz Antonio J.¹,Robertson Michele²,Catapano Alberico L.³,Watts Gerald F.⁴,Kastelein John J.⁵,Packard Chris J.⁶,Ford Ian²,Ray Kausik K.¹

Affiliation:

1. Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, United Kingdom (A.J.V.-V., K.K.R.).

2. Robertson Centre for Biostatistics, University of Glasgow, United Kingdom (M.R., I.F.).

3. Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano and IRCCS Multimedica, Italy (A.L.C.).

4. Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia (G.F.W.).

5. Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands (J.J.K.).

6. College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom (C.J.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

2. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

3. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype

4. Orringer CE Jacobson TA Saseen JJ Brown AS Gotto AM Ross JL Underberg JA. Update on the use of PCSK9 inhibitors in adults: recommendations from an Expert Panel of the National Lipid Association. J Clin Lipidol . 2017; 11 :880–890. doi: 10.1016/j.jacl.2017.05.001.

5. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease;PLOS ONE;2024-07-10

2. Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis;Frontiers in Endocrinology;2024-05-31

3. Clinical profile and practice patterns of patients with severe hypercholesterolemia: A Hospital-based registry;Nepalese Heart Journal;2024-05-31

4. Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials;Journal of Clinical Lipidology;2024-03

5. First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults;Journal of Research in Medical Sciences;2024-03